1. Home
  2. BWFG vs YDES Comparison

BWFG vs YDES Comparison

Compare BWFG & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bankwell Financial Group Inc.

BWFG

Bankwell Financial Group Inc.

HOLD

Current Price

$62.21

Market Cap

475.4M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.24

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWFG
YDES
Founded
2002
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
475.4M
543.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
BWFG
YDES
Price
$62.21
$2.24
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$55.00
N/A
AVG Volume (30 Days)
81.7K
312.1K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
1.52%
N/A
EPS Growth
261.79
N/A
EPS
1.41
N/A
Revenue
$2,826,000.00
N/A
Revenue This Year
$17.64
N/A
Revenue Next Year
$6.21
N/A
P/E Ratio
$42.96
N/A
Revenue Growth
43.96
N/A
52 Week Low
$38.20
$1.70
52 Week High
$61.86
$25.00

Technical Indicators

Market Signals
Indicator
BWFG
YDES
Relative Strength Index (RSI) 66.73 44.84
Support Level $45.62 $2.14
Resistance Level N/A $3.05
Average True Range (ATR) 1.87 0.32
MACD 0.09 0.07
Stochastic Oscillator 95.77 59.36

Price Performance

Historical Comparison
BWFG
YDES

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: